CN108925994A - 一种铁锌钙复合维生素营养口服液及其制备方法 - Google Patents
一种铁锌钙复合维生素营养口服液及其制备方法 Download PDFInfo
- Publication number
- CN108925994A CN108925994A CN201810945302.4A CN201810945302A CN108925994A CN 108925994 A CN108925994 A CN 108925994A CN 201810945302 A CN201810945302 A CN 201810945302A CN 108925994 A CN108925994 A CN 108925994A
- Authority
- CN
- China
- Prior art keywords
- iron
- zinc
- calcium
- ginseng extract
- leaching liquor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000011782 vitamin Substances 0.000 title claims abstract description 26
- 229940088594 vitamin Drugs 0.000 title claims abstract description 26
- JYMOQWNEIZBVFC-UHFFFAOYSA-N [Fe].[Zn].[Ca] Chemical compound [Fe].[Zn].[Ca] JYMOQWNEIZBVFC-UHFFFAOYSA-N 0.000 title claims abstract description 24
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 24
- 230000035764 nutrition Effects 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims description 16
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 80
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 66
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 56
- 235000020710 ginseng extract Nutrition 0.000 claims abstract description 48
- 210000000582 semen Anatomy 0.000 claims abstract description 45
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 44
- 229910052742 iron Inorganic materials 0.000 claims abstract description 40
- 239000011575 calcium Substances 0.000 claims abstract description 36
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 35
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 35
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 35
- 239000011701 zinc Substances 0.000 claims abstract description 35
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 35
- 229930006000 Sucrose Natural products 0.000 claims abstract description 34
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 34
- 239000005720 sucrose Substances 0.000 claims abstract description 34
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 33
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 33
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 33
- 239000011718 vitamin C Substances 0.000 claims abstract description 33
- 229920001202 Inulin Polymers 0.000 claims abstract description 31
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 31
- 229940029339 inulin Drugs 0.000 claims abstract description 31
- 239000000796 flavoring agent Substances 0.000 claims abstract description 29
- 229960003080 taurine Drugs 0.000 claims abstract description 28
- 235000019634 flavors Nutrition 0.000 claims abstract description 27
- 238000002386 leaching Methods 0.000 claims description 60
- 238000001914 filtration Methods 0.000 claims description 30
- 239000002994 raw material Substances 0.000 claims description 30
- 238000010438 heat treatment Methods 0.000 claims description 29
- 230000001954 sterilising effect Effects 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 12
- 238000004659 sterilization and disinfection Methods 0.000 claims description 12
- 238000007654 immersion Methods 0.000 claims description 11
- 239000012153 distilled water Substances 0.000 claims description 10
- 238000011049 filling Methods 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 3
- SVBWNHOBPFJIRU-UHFFFAOYSA-N 1-O-alpha-D-Glucopyranosyl-D-fructose Natural products OC1C(O)C(O)C(CO)OC1OCC1(O)C(O)C(O)C(O)CO1 SVBWNHOBPFJIRU-UHFFFAOYSA-N 0.000 claims description 2
- 244000144730 Amygdalus persica Species 0.000 claims description 2
- 235000005979 Citrus limon Nutrition 0.000 claims description 2
- 244000131522 Citrus pyriformis Species 0.000 claims description 2
- 240000008397 Ganoderma lucidum Species 0.000 claims description 2
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 2
- 235000020237 cranberry extract Nutrition 0.000 claims description 2
- 235000012907 honey Nutrition 0.000 claims description 2
- NMXLJRHBJVMYPD-IPFGBZKGSA-N trehalulose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@]1(O)CO[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 NMXLJRHBJVMYPD-IPFGBZKGSA-N 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims 2
- 229930091371 Fructose Natural products 0.000 claims 2
- 239000002304 perfume Substances 0.000 claims 2
- 238000010521 absorption reaction Methods 0.000 abstract description 7
- 239000000470 constituent Substances 0.000 abstract description 5
- 239000013589 supplement Substances 0.000 abstract description 5
- 230000002641 glycemic effect Effects 0.000 abstract description 4
- 230000002035 prolonged effect Effects 0.000 abstract description 4
- 235000013361 beverage Nutrition 0.000 abstract description 3
- 230000001502 supplementing effect Effects 0.000 abstract description 2
- 241000894006 Bacteria Species 0.000 description 9
- 238000004140 cleaning Methods 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 241000208340 Araliaceae Species 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
- 239000005864 Sulphur Substances 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- 240000000111 Saccharum officinarum Species 0.000 description 2
- 235000007201 Saccharum officinarum Nutrition 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 2
- 240000008866 Ziziphus nummularia Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- VAJVDSVGBWFCLW-UHFFFAOYSA-N 3-Phenyl-1-propanol Chemical compound OCCCC1=CC=CC=C1 VAJVDSVGBWFCLW-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 102000008857 Ferritin Human genes 0.000 description 1
- 108050000784 Ferritin Proteins 0.000 description 1
- 238000008416 Ferritin Methods 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000008892 Helianthus tuberosus Species 0.000 description 1
- 235000003230 Helianthus tuberosus Nutrition 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022971 Iron Deficiencies Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010027540 Microcytosis Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- SNIXRMIHFOIVBB-UHFFFAOYSA-N N-Hydroxyl-tryptamine Chemical compound C1=CC=C2C(CCNO)=CNC2=C1 SNIXRMIHFOIVBB-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- FLDFNEBHEXLZRX-DLQNOBSRSA-N Nystose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FLDFNEBHEXLZRX-DLQNOBSRSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- DYUQAZSOFZSPHD-UHFFFAOYSA-N Phenylpropyl alcohol Natural products CCC(O)C1=CC=CC=C1 DYUQAZSOFZSPHD-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000022440 X-linked sideroblastic anemia 1 Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- -1 coumarin glucoside Chemical class 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 210000003617 erythrocyte membrane Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 150000002584 ketoses Chemical class 0.000 description 1
- 229940118199 levulan Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000008111 motor development Effects 0.000 description 1
- 208000037890 multiple organ injury Diseases 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- FLDFNEBHEXLZRX-UHFFFAOYSA-N nystose Natural products OC1C(O)C(CO)OC1(CO)OCC1(OCC2(OC3C(C(O)C(O)C(CO)O3)O)C(C(O)C(CO)O2)O)C(O)C(O)C(CO)O1 FLDFNEBHEXLZRX-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开了一种铁锌钙复合维生素营养口服液,由以下重量份组分组成:菊粉锌:0.6~1份,维生素C:1~3.5份,人参提取物:0.5~1.5份,补铁剂:4~7份,低聚果糖钙:4~7份,牛磺酸:1~2份,灵芝提取物:0.05~0.2份,酸枣仁:0.15~0.3份,天然香味剂:0.1~0.4份,蔗糖转化糖:4~6份,其余组成为水。本发明具有补充铁元素和维生素C、人参提取物的功能,同时能够高效补充铁、锌和钙元素,吸收效率高;通过蔗糖转化糖增加能够延长血糖峰值时间,使能量供给时间大幅延长,长时间的血糖峰值促进饮料中的功能成分更好的发挥作用。
Description
技术领域
本发明涉及功能饮料领域,具体是一种铁锌钙复合维生素营养口服液及其制备方法。
背景技术
营养性贫血是一种小细胞低色素性贫血,由体内铁缺乏造成血红蛋白合成减少所引起,临床以血清铁浓度、转铁蛋白饱和度和血清铁蛋白降低,采用铁剂治疗有效为特征,主要症状有面色苍白或萎黄、唇甲色淡、倦怠乏力、食欲不振等。世界约有10~30%的人群有不同程度的缺铁,尤其是婴幼儿发病率更高。它不仅影响小儿生长发育及多脏器损伤,对儿童智能潜在的远期损害和运动发展的迟滞常常是不可逆转的,同时也是导致细胞免疫、体液免疫功能受损而经常引起感染及健康水平下降的重要原因。
目前市场上充斥着各种各样、参差不齐的消食开胃的维C铁、锌、钙口服液,效果各异,但是大多治标不治本,无法从根本上解决问题。
发明内容
本发明的目的在于提供一种铁锌钙复合维生素营养口服液及其制备方法,以解决上述背景技术中提出的问题。
为实现上述目的,本发明提供如下技术方案:
一种铁锌钙复合维生素营养口服液,由以下重量份组分组成:
菊粉锌:0.6~1份,维生素C:1~3.5份,人参提取物:0.5~1.5份,补铁剂:4~7份,低聚果糖钙:4~7份,牛磺酸:1~2份,灵芝提取物:0.05~ 0.2份,酸枣仁:0.15~0.3份,天然香味剂:0.1~0.4份,蔗糖转化糖:4~ 6份,其余组成为水。
作为本发明进一步的方案:所述天然香味剂为蔓越莓提取物、水蜜桃提取物、苹果提取物和柠檬提取物中的一种或多种。
作为本发明进一步的方案:所述蔗糖转化糖为异麦芽酮糖和海藻酮糖的混合物。
作为本发明进一步的方案:菊粉锌:0.6g,维生素C:1g,人参提取物: 0.5g,补铁剂:4g,低聚果糖钙:4g,牛磺酸:1g,灵芝提取物:0.05g,酸枣仁:0.15g,天然香味剂:0.1g,蔗糖转化糖:4g。
作为本发明进一步的方案:菊粉锌:0.8g,维生素C:2g,人参提取物: 1g,补铁剂:5.5g,低聚果糖钙:5.5g,牛磺酸:1.5g,灵芝提取物:0.1g,酸枣仁:0.22g,天然香味剂:0.25g,蔗糖转化糖:5g。
作为本发明进一步的方案:菊粉锌:1g,维生素C:3.5g,人参提取物: 1.5g,补铁剂:7g,低聚果糖钙:7g,牛磺酸:2g,灵芝提取物:0.2g,酸枣仁:0.3g,天然香味剂:0.4g,蔗糖转化糖:6g。
一种铁锌钙复合维生素营养口服液的制备方法,包括以下步骤:
(1)将人参提取物、灵芝提取物、酸枣仁原料洗净后加水浸泡,浸泡5小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到一次浸提液,备用;
(2)加水浸泡步骤(1)中的人参提取物、灵芝提取物、酸枣仁原料余料,第二次浸泡1小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到二次浸提液,备用;
(3)加水浸泡步骤(2)中的人参提取物、灵芝提取物、酸枣仁原料余料,第三次浸泡1小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到三次浸提液,备用;
(4)将一次浸提液、二次浸提液、三次浸提液混合,加入菊粉锌、维生素 C、补铁剂、低聚果糖钙、牛磺酸、天然香味剂和蔗糖转化糖,加蒸馏水,加入到杀菌釜中进行30分钟灭菌处理,即可分瓶灌装。
与现有技术相比,本发明的有益效果是:具有补充铁元素和维生素C的功能,同时能够高效补充铁、锌和钙元素,吸收效率高;通过蔗糖转化糖增加能够延长血糖峰值时间,使能量供给时间大幅延长,长时间的血糖峰值促进饮料中的功能成分更好的发挥作用。
具体实施方式
下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
本发明实施例中,一种铁锌钙复合维生素营养口服液及其制备方法,由以下配方组成:
菊粉锌:0.6~1份,维生素C:1~3.5份,人参提取物:0.5~1.5份,补铁剂:4~7份,低聚果糖钙:4~7份,牛磺酸:1~2份,灵芝提取物:0.05~ 0.2份,酸枣仁:0.15~0.3份,天然香味剂:0.1~0.4份,蔗糖转化糖:4~ 6份,其余组成为水。
在上述组分中,
菊粉锌:菊粉锌通过进行碱化和醚化后,与锌离子螯合制得,相对普通的锌离子化合物,更易于人体吸收;
维生素C:维生素C为抗体及胶原形成,组织修补(包括某些氧化还原作用),苯丙氨酸、酪氨酸、叶酸的代谢,铁、碳水化合物的利用,脂肪、蛋白质的合成,维持免疫功能,羟化与羟色胺,保持血管的完整,促进非血红素铁吸收等所必需,同时维生素C还具备有抗氧化,抗自由基,抑制酪氨酸酶的形成,从而达到美白,淡斑的功效;
人参提取物:人参味甘、微苦,性微温,归脾、肺、心、肾经,气雄体润,升多于降;具有补气固脱,健脾益肺,宁心益智,养血生津的功效;人参主治大病、久病、失血、脱液所致元气欲脱,神疲脉微;脾气不足之食少倦怠,呕吐泄泻;肺气虚弱之气短喘促,咳嗽无力。心气虚衰之失眠多梦,惊悸健忘,体虚多汗。津亏之口渴,消渴,血虚之萎黄,眩晕,肾虚阳萎,尿频,气虚外感;
补铁剂:与胺基酸(蛋白质)螯合的铁剂,不会与食物中的酸性物质产生不溶性盐而降低吸收率,同时也不会造成便秘的副作用;
低聚果糖钙:低聚果糖又称蔗果低聚糖,是由1~3个果糖基通过β(2-1) 糖苷键与蔗糖中的果糖基结合生成的蔗果三糖、蔗果四糖和蔗果五糖等的混合物,100克干重菊芋中约有60-70克菊粉,菊粉是通过线性的β-2,1-糖苷链连接的果聚糖,其末端为一蔗糖基,低聚果糖和钙通过将低聚果糖进行碱化和醚化后,与钙离子螯合制得,能够更好的促进钙的吸收;
牛磺酸:能够促进婴幼儿脑组织和智力发育;提高神经传导和视觉机能;防止心血管病;促进脂类的吸收;改善内分泌状态,增强人体免疫;促进糖代谢;抑制白内障的发生发展;改善记忆的功能;维持正常生殖功能;防治缺铁性贫血有明显效果,它不仅可以促进肠道对铁的吸收,还可增加红细胞膜的稳定性;牛磺酸还是人体肠道内双歧菌的促生因子,优化肠道内细菌群结构;还具有抗氧化、延缓衰老作用;能够促进急性肝炎恢复正常;对四氯化碳中毒有保护作用,并能抑制由此所引起的血清谷丙转氨酶的升高。对肾毒性有保护作用,牛磺酸对顺铂所致的兔原代肾小管上皮细胞改变有保护作用;牛磺酸可镇静、镇痛和消炎,对冻伤、KCN中毒及偏头疼也有防治作用;
灵芝提取物:主含氨基酸、多肽、蛋白质、真菌溶菌酶(fungal lysozyme),以及糖类(还原糖和多糖)、麦角甾醇、三萜类、香豆精甙、挥发油、硬脂酸、苯甲酸、生物碱、人参提取物及C等;孢子还含甘露醇、海藻糖(trehalose);
酸枣仁:本品为鼠李科植物酸枣的种子,秋季果实成熟时采收,将果实浸泡一宿,搓去果肉,捞出,用石碾碾碎果核,取出种子,晒干;功能主治养肝,宁心,安神,敛汗,治虚烦不眠,惊悸怔忡,烦渴,虚汗;①《本经》:主心腹寒热,邪结气聚,四肢酸疼,湿痹;②《别录》:主烦心不得眠,脐上下痛,血转久泄,虚汗烦渴,补中,益肝气,坚筋骨,助阴气,令人肥健;③《药性论》:主筋骨风,炒末作汤服之;④《本草拾遗》:睡多生使,不得睡炒熟;⑤王好古:治胆虚不眠,寒也,炒服;治胆实多睡,热也,生用;⑥《本草汇言》:敛气安神,荣筋养髓,和胃运脾;⑦《本草再新》:平肝理气,润肺养阴,温中利湿,敛气止汗,益志定呵,聪耳明目。
采用上述组分制成的饮品,具有补充铁元素和维生素C、人参提取物的功能,同时能够高效补充铁、锌和钙元素,吸收效率高。
实施例1
菊粉锌:0.6g,维生素C:1g,人参提取物:0.5g,补铁剂:4g,低聚果糖钙:4g,牛磺酸:1g,灵芝提取物:0.05g,酸枣仁:0.15g,天然香味剂: 0.1g,蔗糖转化糖:4g。
一种铁锌钙复合维生素营养口服液的制备方法,包括以下步骤:
(1)将人参提取物、灵芝提取物、酸枣仁原料洗净后加水浸泡,浸泡5小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到一次浸提液,备用;
(2)加水浸泡步骤(1)中的人参提取物、灵芝提取物、酸枣仁原料余料,第二次浸泡1小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到二次浸提液,备用;
(3)加水浸泡步骤(2)中的人参提取物、灵芝提取物、酸枣仁原料余料,第三次浸泡1小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到三次浸提液,备用;
(4)将一次浸提液、二次浸提液、三次浸提液混合,加入菊粉锌、维生素 C、补铁剂、低聚果糖钙、牛磺酸、天然香味剂和蔗糖转化糖,加蒸馏水,加入到杀菌釜中进行30分钟灭菌处理,即可分瓶灌装。
实施例2
菊粉锌:0.8g,维生素C:2g,人参提取物:1g,补铁剂:5.5g,低聚果糖钙:5.5g,牛磺酸:1.5g,灵芝提取物:0.1g,酸枣仁:0.22g,天然香味剂:0.25g,蔗糖转化糖:5g。
一种铁锌钙复合维生素营养口服液的制备方法,包括以下步骤:
(1)人参提取物、灵芝提取物、酸枣仁原料洗净后加水浸泡,浸泡5小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到一次浸提液,备用;
(2)加水浸泡步骤(1)中的人参提取物、灵芝提取物、酸枣仁原料余料,第二次浸泡1小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到二次浸提液,备用;
(3)加水浸泡步骤(2)中的人参提取物、灵芝提取物、酸枣仁原料余料,第三次浸泡1小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到三次浸提液,备用;
(4)将一次浸提液、二次浸提液、三次浸提液混合,加入菊粉锌、维生素C、补铁剂、低聚果糖钙、牛磺酸、天然香味剂和蔗糖转化糖,加蒸馏水,加入到杀菌釜中进行30分钟灭菌处理,即可分瓶灌装。
实施例3
菊粉锌:1g,维生素C:3.5g,人参提取物:1.5g,补铁剂:7g,低聚果糖钙:7g,牛磺酸:2g,灵芝提取物:0.2g,酸枣仁:0.3g,天然香味剂: 0.4g,蔗糖转化糖:6g。
一种铁锌钙复合维生素营养口服液的制备方法,包括以下步骤:
(1)将人参提取物、灵芝提取物、酸枣仁原料洗净后加水浸泡,浸泡5小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到一次浸提液,备用;
(2)加水浸泡步骤(1)中的人参提取物、灵芝提取物、酸枣仁原料余料,第二次浸泡1小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到二次浸提液,备用;
(3)加水浸泡步骤(2)中的人参提取物、灵芝提取物、酸枣仁原料余料,第三次浸泡1小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到三次浸提液,备用;
(4)将一次浸提液、二次浸提液、三次浸提液混合,加入菊粉锌、维生素 C、补铁剂、低聚果糖钙、牛磺酸、天然香味剂和蔗糖转化糖,加蒸馏水,加入到杀菌釜中进行30分钟灭菌处理,即可分瓶灌装。
对比例1
维生素C:3.5g,人参提取物:1.5g,补铁剂:7g,低聚果糖钙7g,牛磺酸:2g,灵芝提取物:0.2g,酸枣仁:0.3g,天然香味剂:0.4g,蔗糖转化糖:6g。
一种铁锌钙复合维生素营养口服液的制备方法,包括以下步骤:
(1)将人参提取物、灵芝提取物、酸枣仁原料洗净后加水浸泡,浸泡5小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到一次浸提液,备用;
(2)加水浸泡步骤(1)中的人参提取物、灵芝提取物、酸枣仁原料余料,第二次浸泡1小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到二次浸提液,备用;
(3)加水浸泡步骤(2)中的人参提取物、灵芝提取物、酸枣仁原料余料,第三次浸泡1小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到三次浸提液,备用;
(4)将一次浸提液、二次浸提液、三次浸提液混合,加入维生素C、补铁剂、低聚果糖钙、牛磺酸、天然香味剂和蔗糖转化糖,加蒸馏水,加入到杀菌釜中进行30分钟灭菌处理,即可分瓶灌装。
对比例2
菊粉锌:1g,维生素C:3.5g,人参提取物:1.5g,补铁剂:7g,低聚果糖钙7g,牛磺酸:2g,酸枣仁:0.3g,天然香味剂:0.4g,蔗糖转化糖:6g。
一种铁锌钙复合维生素营养口服液的制备方法,包括以下步骤:
(1)将人参提取物、酸枣仁原料洗净后加水浸泡,浸泡5小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到一次浸提液,备用;
(2)加水浸泡步骤(1)中的人参提取物、酸枣仁原料余料,第二次浸泡1 小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到二次浸提液,备用;
(3)加水浸泡步骤(2)中的人参提取物、酸枣仁原料余料,第三次浸泡1 小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到三次浸提液,备用;
(4)将一次浸提液、二次浸提液、三次浸提液混合,加菊粉锌、入维生素 C、补铁剂、低聚果糖钙、牛磺酸、天然香味剂和蔗糖转化糖,加蒸馏水,加入到杀菌釜中进行30分钟灭菌处理,即可分瓶灌装。
对比例3
菊粉锌:1g,维生素C:3.5g,人参提取物:1.5g,补铁剂:7g,低聚果糖钙7g,牛磺酸:2g,灵芝提取物:0.2g,天然香味剂:0.4g,蔗糖转化糖: 6g。
一种铁锌钙复合维生素营养口服液的制备方法,包括以下步骤:
(1)将人参提取物、灵芝提取物原料洗净后加水浸泡,浸泡5小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到一次浸提液,备用;
(2)加水浸泡步骤(1)中的人参提取物、灵芝提取物原料余料,第二次浸泡1小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到二次浸提液,备用;
(3)加水浸泡步骤(2)中的人参提取物、灵芝提取物原料余料,第三次浸泡1小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到三次浸提液,备用;
(4)将一次浸提液、二次浸提液、三次浸提液混合,加入菊粉锌、维生素 C、补铁剂、低聚果糖钙、牛磺酸、天然香味剂和蔗糖转化糖,加蒸馏水,加入到杀菌釜中进行30分钟灭菌处理,即可分瓶灌装。
对比例4
菊粉锌:1g,维生素C:3.5g,人参提取物:1.5g,补铁剂:7g,灵芝提取物:0.2g,酸枣仁:0.3g,天然香味剂:0.4g,蔗糖转化糖:6g。
一种铁锌钙复合维生素营养口服液的制备方法,包括以下步骤:
(1)将人参提取物、灵芝提取物、酸枣仁原料洗净后加水浸泡,浸泡5小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到一次浸提液,备用;
(2)加水浸泡步骤(1)中的人参提取物、灵芝提取物、酸枣仁原料余料,第二次浸泡1小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到二次浸提液,备用;
(3)加水浸泡步骤(2)中的人参提取物、灵芝提取物、酸枣仁原料余料,第三次浸泡1小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到三次浸提液,备用;
(4)将一次浸提液、二次浸提液、三次浸提液混合,加菊粉锌、入维生素 C、补铁剂、天然香味剂和蔗糖转化糖,加蒸馏水,加入到杀菌釜中进行30 分钟灭菌处理,即可分瓶灌装。
对比例5
菊粉锌:1g,维生素C:3.5g,补铁剂:7g,低聚果糖钙7g,牛磺酸:2g,灵芝提取物:0.2g,酸枣仁:0.3g,天然香味剂:0.4g,蔗糖转化糖:6g。
一种铁锌钙复合维生素营养口服液的制备方法,包括以下步骤:
(1)将灵芝提取物、酸枣仁原料洗净后加水浸泡,浸泡5小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到一次浸提液,备用;
(2)加水浸泡步骤(1)中的灵芝提取物、酸枣仁原料余料,第二次浸泡1 小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到二次浸提液,备用;
(3)加水浸泡步骤(2)中的灵芝提取物、酸枣仁原料余料,第三次浸泡1 小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到三次浸提液,备用;
(4)将一次浸提液、二次浸提液、三次浸提液混合,加菊粉锌、入维生素 C、补铁剂、低聚果糖钙、牛磺酸、天然香味剂和蔗糖转化糖,加蒸馏水,加入到杀菌釜中进行30分钟灭菌处理,即可分瓶灌装。
通过实施例1-3和对比例1-5所制备产品的小白鼠活体检测使用,本申请中配方具有有效补充铁、锌、钙元素及维生素的功能,通过实施例的对比可以发现菊粉锌、人参提取物、低聚果糖钙、牛磺酸、灵芝提取物和酸枣仁的含量对于铁、锌、钙元素和维生素的补充有促进作用,通过对比例的对比可以发现,各组分均具有相应的元素补充效果,但多组分配合具有更好的促进作用,蔗糖转化糖的增加能够使能量供给时间大幅延长,长时间的血糖峰值促进饮料中的功能成分更好的发挥作用。
对于本领域技术人员而言,显然本发明不限于上述示范性实施例的细节,而且在不背离本发明的精神或基本特征的情况下,能够以其他的具体形式实现本发明。因此,无论从哪一点来看,均应将实施例看作是示范性的,而且是非限制性的,本发明的范围由所附权利要求而不是上述说明限定,因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内。
此外,应当理解,虽然本说明书按照实施方式加以描述,但并非每个实施方式仅包含一个独立的技术方案,说明书的这种叙述方式仅仅是为清楚起见,本领域技术人员应当将说明书作为一个整体,各实施例中的技术方案也可以经适当组合,形成本领域技术人员可以理解的其他实施方式。
Claims (7)
1.一种铁锌钙复合维生素营养口服液,其特征在于,由以下重量份组分组成:
菊粉锌:0.6~1份,维生素C:1~3.5份,人参提取物:0.5~1.5份,补铁剂:4~7份,低聚果糖钙:4~7份,牛磺酸:1~2份,灵芝提取物:0.05~0.2份,酸枣仁:0.15~0.3份,天然香味剂:0.1~0.4份,蔗糖转化糖:4~6份,其余组成为水。
2.根据权利要求1所述的一种铁锌钙复合维生素营养口服液,其特征在于,所述天然香味剂为蔓越莓提取物、水蜜桃提取物、苹果提取物和柠檬提取物中的一种或多种。
3.根据权利要求1所述的一种铁锌钙复合维生素营养口服液及其制备方法,其特征在于,所述蔗糖转化糖为异麦芽酮糖和海藻酮糖的混合物。
4.根据权利要求1所述的一种铁锌钙复合维生素营养口服液,其特征在于,菊粉锌:0.6g,维生素C:1g,人参提取物:0.5g,补铁剂:4g,低聚果糖钙:4g,牛磺酸:1g,灵芝提取物:0.05g,酸枣仁:0.15g,天然香味剂:0.1g,蔗糖转化糖:4g。
5.根据权利要求1所述的一种铁锌钙复合维生素营养口服液,其特征在于,菊粉锌:0.8g,维生素C:2g,人参提取物:1g,补铁剂:5.5g,低聚果糖钙:5.5g,牛磺酸:1.5g,灵芝提取物:0.1g,酸枣仁:0.22g,天然香味剂:0.25g,蔗糖转化糖:5g。
6.根据权利要求1所述的一种铁锌钙复合维生素营养口服液,其特征在于,菊粉锌:1g,维生素C:3.5g,人参提取物:1.5g,补铁剂:7g,低聚果糖钙:7g,牛磺酸:2g,灵芝提取物:0.2g,酸枣仁:0.3g,天然香味剂:0.4g,蔗糖转化糖:6g。
7.根据权利要求1所述的一种铁锌钙复合维生素营养口服液,其特征在于,所述的一种铁锌钙复合维生素营养口服液的制备方法,包括以下步骤:
(1)将人参提取物、灵芝提取物、酸枣仁原料洗净后加水浸泡,浸泡5小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到一次浸提液,备用;
(2)加水浸泡步骤(1)中的人参提取物、灵芝提取物、酸枣仁原料余料,第二次浸泡1小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到二次浸提液,备用;
(3)加水浸泡步骤(2)中的人参提取物、灵芝提取物、酸枣仁原料余料,第三次浸泡1小时,在容器中加热煎熬45分钟,经200目滤筛过滤得到三次浸提液,备用;
(4)将一次浸提液、二次浸提液、三次浸提液混合,加入菊粉锌、维生素C、补铁剂、低聚果糖钙、牛磺酸、天然香味剂和蔗糖转化糖,加蒸馏水,加入到杀菌釜中进行30分钟灭菌处理,即可分瓶灌装。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810945302.4A CN108925994A (zh) | 2018-08-17 | 2018-08-17 | 一种铁锌钙复合维生素营养口服液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810945302.4A CN108925994A (zh) | 2018-08-17 | 2018-08-17 | 一种铁锌钙复合维生素营养口服液及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108925994A true CN108925994A (zh) | 2018-12-04 |
Family
ID=64445957
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810945302.4A Withdrawn CN108925994A (zh) | 2018-08-17 | 2018-08-17 | 一种铁锌钙复合维生素营养口服液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108925994A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020237340A1 (pt) * | 2019-05-31 | 2020-12-03 | Rischbieter Ivo | Suplemento alimentar de alta-energia baseado em açúcares invertidos e produtos ergogênicos para uso em atividades físicas e seu processo de produção |
-
2018
- 2018-08-17 CN CN201810945302.4A patent/CN108925994A/zh not_active Withdrawn
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020237340A1 (pt) * | 2019-05-31 | 2020-12-03 | Rischbieter Ivo | Suplemento alimentar de alta-energia baseado em açúcares invertidos e produtos ergogênicos para uso em atividades físicas e seu processo de produção |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102224953B (zh) | 一种丰胸美乳保健饮料 | |
CN103960729B (zh) | 低糖黑蒜花卉饮料及制备方法 | |
CN102640822B (zh) | 一种保健茶膏及其制备方法 | |
CN113180165A (zh) | 一种含透明质酸钠的养颜饮料及其制备方法 | |
CN101716007A (zh) | 一种肉桂生姜保健饮料及其制备方法 | |
CN104256783A (zh) | 一种山药枣杞饮料及其制备方法 | |
CN106889405A (zh) | 一种富硒百香果饮品及其制备方法 | |
CN101103796B (zh) | 一种菌类调味品及其制备方法 | |
CN109222100A (zh) | 一种人参蛹虫草组合物、人参蛹虫草压片糖果及其制备方法 | |
CN109329427A (zh) | 一种美容养颜的茉莉花纯露水果奶茶及其制作方法 | |
CN104256782B (zh) | 一种葛根山杞饮料及其制备方法 | |
CN108925994A (zh) | 一种铁锌钙复合维生素营养口服液及其制备方法 | |
CN103520302B (zh) | 一种沙棘叶抗疲劳胶囊及其制备方法 | |
CN109730222A (zh) | 酵素复合液及其保健饮料 | |
CN102224893A (zh) | 保健口服液 | |
CN101991110A (zh) | 野生灵芝系列食品 | |
CN103468494A (zh) | 一种补酒的制备方法 | |
CN106800992A (zh) | 桑椹阿胶人参酒及其制备方法 | |
KR100232720B1 (ko) | 자라를 이용한 음료제조 방법 | |
CN103005439A (zh) | 一种苦瓜复方降脂口服液及其制备方法 | |
CN106857937A (zh) | 一种具有辅助降血压功效的龙胆槐菊茶饮料 | |
CN103789147A (zh) | 一种山楂长生固本酒 | |
CN1565205A (zh) | 睡奶 | |
KR20210041387A (ko) | 갈화 추출물 및 차전자피 분말을 함유한 숙취해소용 천연차 및 그 제조방법 | |
KR20090021410A (ko) | 피로할 때 마시는 대추 침출 차 조성물과 그 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |